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Abstract
Background: Glucose inhibition of gluconeogenic growth suppressor 2 protein (Gis2p) and zinc-finger protein
9 (ZNF9) are conserved yeast and human zinc-finger proteins. The function of yeast Gis2p is unknown, but human
ZNF9 has been reported to bind nucleic acids, and mutations in the ZNF9 gene cause the neuromuscular disease
myotonic dystrophy type 2. To explore the impact of these proteins on RNA regulation, we undertook a systematic
analysis of the RNA targets and of the global implications for gene expression.
Results: Hundreds of mRNAs were associated with Gis2p, mainly coding for RNA processing factors, chromatin
modifiers and GTPases. Target mRNAs contained stretches of G(A/U)(A/U) trinucleotide repeats located in coding
sequences, which are sufficient for binding to both Gis2p and ZNF9, thus implying strong structural conservation.
Predicted ZNF9 targets belong to the same functional categories as seen in yeast, indicating functional
conservation, which is further supported by complementation of the large cell-size phenotype of gis2 mutants with
ZNF9. We further applied a matched-sample proteome-transcriptome analysis suggesting that Gis2p differentially
coordinates expression of RNA regulons, primarily by reducing mRNA and protein levels of genes required for
ribosome assembly and by selectively up-regulating protein levels of myosins.
Conclusions: This integrated systematic exploration of RNA targets for homologous RNA-binding proteins indicates
an unexpectedly high conservation of the RNA-binding properties and of potential targets, thus predicting
conserved RNA regulons. We also predict regulation of muscle-specific genes by ZNF9, adding a potential link to
the myotonic dystrophy related phenotypes seen in ZNF9 mouse models.
Background
Post-transcriptional gene regulation is thought to contri-
bute to the limited correlation between mRNA and
protein levels in cells [1-4]. A pivotal role for post-tran-
scriptional gene regulation is assigned to RNA-binding
proteins (RBPs), which control almost every aspect of a
RNA’s life, including RNA processing, splicing, export,
localization, decay and translation in the cytoplasm [5,6].
An increasing number of studies in diverse model organ-
isms, applying genomic tools such as DNA microarrays or
next-generation sequencing, revealed that RBPs specifi-
cally bind to distinct RNA groups that often encode func-
tionally related proteins [7-9]. Such organization of RNAs
into ‘post-transcriptional operons’ or ‘RNA regulons’ may
allow the coherent coordination of mRNA fates [5,10,11].
However, how such coordination by RBPs impacts gene
expression at the mRNA and protein levels remains largely
elusive.
RBPs are often composed of an array of RNA-binding
domains that ultimately define RNA-binding specificity.
Zinc-finger (ZnF) domains are common, relatively small
protein motifs that contain conserved cysteine and histi-
dine residues coordinated to zinc ions. First identified as
specific DNA-binding motifs in transcription factors,
many different types of ZnF motifs have now been char-
acterized interacting specifically with DNA, RNA, pro-
teins, and lipids [12-14]. Gis2 (Glucose inhibition of
gluconeogenic growth suppressor 2) from the yeast Sac-
charomyces cerevisiae is a cytoplasmic protein that con-
tains seven CCHC or ‘retroviral’-type ZnF motifs, which
are predicted to mediate DNA and possibly RNA interac-
tions. The GIS2 gene was originally identified in a screen
for multicopy suppressors of the galactose utilization
defect of snf1 mig1 srb8/10/11 triple mutants, where it
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genetically interacted with CDC25, establishing a func-
tional connection to the Ras/cAMP pathway [15]. In a
global screen for mutants with altered cell size, gis2Δ
mutants were found to display increased cell sizes [16].
Furthermore, an extensive bioinformatics study integrat-
ing a variety of microarray-based gene expression profile
data suggested that Gis2 is co-regulated with factors con-
tributing to cytoplasmic ribosome function - some of
them crucial for cell size control - predicting roles of
Gis2p in ribosome biogenesis [17,18].
The human homolog of Gis2p, termed ZNF9 or cellu-
lar nucleic acid binding protein (CNBP), contains an
additional arginine-glycine-glycine (RGG)-rich motif
located between the first and the second of the seven
ZnFs (the domain structure and a multiple amino acid
sequence alignment is shown in Additional file 1). The
protein was first described to bind to purine-rich single-
stranded DNA (ssDNA) of the sterol response element,
possibly playing a role in sterol metabolism [19]. Several
studies further suggested functions of ZNF9 as a positive
or negative regulator of transcription by binding to gua-
nosine-rich ssDNA sequences: ZNF9 represses the
expression of the beta-myosin heavy chain [20] and the
JC virus control region [21], whereas it activates expres-
sion of the c-myc oncogene [22] and macrophage colony-
stimulating factor (M-CSF) [23]. ZNF9 has also been
suggested to interact with RNA [24], possibly regulating
translation of ribosomal protein mRNA in the frog Xeno-
pus laevis [25], or promoting cap-independent translation
of ornithine decarboxylase [26,27]. Importantly, ZNF9
has been shown to interact with the 5’-UTR of terminal
oligopyrimidine (TOP) tract mRNAs in mammals, and
modulates translation efficiency [27].
ZNF9 attracted great interest when Ranum and col-
leagues [28] found that CCTG nucleotide repeat
expansions in the first intron of ZNF9 cause myotonic
dystrophy type 2 (DM2). DM2 is characterized by het-
erogeneous, multi-systemic symptoms, including myo-
tonia [29]. The disease is thought to be caused by
RNA gain-of-function of the repeats in the spliced-out
intron, which accumulate in nuclear foci sequestering
members of the muscleblind-like (MBNL) family of
RBPs that regulate alternative splicing (reviewed in
[30-32]). The depletion of MBNL1 and other RBPs by
these RNA repeats leads to abnormal splicing of sev-
eral messages important for muscle function, establish-
ing the DM2 phenotype. Phenotypic consequences of
ZNF9 intron repeat expansions are therefore thought
to be indirect and disregard a direct role for ZNF9 in
pathogenesis. Nevertheless, in mice, ZNF9 has substan-
tial impact on proper development, as shown by the
embryonic lethality of ZNF9-/- embryos, which
show severe forebrain truncations [33]. Heterozygous
ZNF9+/- mice show phenotypes that are related to DM,
adding the possibility that ZNF9 may impact on the
expression of muscle-specific genes [34]. Whether
ZNF9 could partly contribute to the pathogenesis of
DM2 is therefore not fully resolved [27,34].
Here, we applied an integrated genomic and proteo-
mic approach to systematically explore the roles of Gis2
and ZNF9 proteins in RNA expression. Using DNA
microarrays, we identified the RNAs that are bound by
Gis2p in yeast cells. This allowed us to decode a con-
served RNA element sufficient for interaction with both
Gis2p and ZNF9. Applying a sample-matched proteo-
mics-transcriptomics approach, we further delineated
both positive and negative effects on expression of func-
tionally coherent groups of mRNAs, suggesting strong
coordinative functions of Gis2p for gene expression.
Finally, based on our results, we predict that human
ZNF9 may coordinate the expression of ribosomal RNA
processing factors and muscle-related genes, which may
relate to phenotypes seen in ZNF9+/- mice.
Results
Gis2p associates with hundreds of mRNAs encoding
functionally related proteins
Gis2p has been predicted to bind nucleic acids because it
contains seven conserved ZnFs, and related proteins in
vertebrates bind to ssDNA or RNA. To validate whether
Gis2p binds RNA and to identify potential target RNAs,
we performed RNA affinity purifications with carboxy-
terminal tandem-affinity purification (TAP)-tagged Gis2p
expressed under the control of its native promoter, and
we identified the associated RNAs with DNA microarrays
(see Materials and methods). Thereby, RNA isolated
from extracts (input) and from the purified samples was
competitively analyzed with yeast DNA oligo arrays that
contained probes for all annotated yeast ORFs and non-
coding RNAs, as well as some intergenic regions. In this
assay, the ratio of the two RNA populations at a given
array element reflects the enrichment of the respective
RNA by Gis2p [7,9].
To select RNAs that were consistently enriched with
Gis2p and hence represent likely targets, we compared
the association of transcripts from three independent
Gis2p affinity purifications with those from five mock
control isolates performed with untagged wild-type cells
using Significance Analysis of Microarrays (SAM) [35],
and determined false discovery rates (FDRs) for each
arrayed feature [8,9]. There were 1,102 features (13.6%
of all 8,132 analyzed features), representing 995 tran-
scripts, associated with Gis2p with FDRs of less than 5%
(Figure 1a; a list of Gis2p targets is given in Additional
file 2; raw data are provided in Additional file 3). Most
of these features represented mRNAs (968 exon probes),
and we did not see an enrichment of non-coding RNAs,
such as rRNAs, tRNAs and small nucleolar RNAs
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(snoRNAs), suggesting a function of Gis2p on spliced
mRNAs in the cytoplasm, which is in agreement with
the protein’s main localization [36]. However, for 39 of
the Gis2p-bound mRNAs, features corresponding to
introns or intron-exon junctions were also significantly
enriched. Possibly, a minor fraction of Gis2p may associ-
ate with some mRNA precursors in the nucleus. We
wish to note that some non-target mRNAs may associ-
ate with Gis2p and true mRNA targets may dissociate
during the affinity-isolation procedure; thus, this assay
may not exclusively and completely uncover target
mRNAs that are associated with Gis2p in vivo [37].
Nevertheless, the identification of a sequence motif
among potential Gis2p/ZNF9 targets, the functional
links among mRNA targets, and the indications for
coordinate expression of functional groups of messages
by Gis2p (see below) strongly suggest an underlying
biological role for many of the interactions we have
identified.
Because many RBPs bind to functionally or cytotopically
related mRNAs, we searched for significantly enriched
Gene Ontology (GO) terms among the Gis2p-associated
messages with AMIGO [38] (a list of significantly
enriched GO terms is given in Additional file 4). Indeed,
Gis2p was associated with functionally related groups of
messages (Figure 1b). Most prominent are messages
coding for proteins involved in ribosome biogenesis (P <
10-16), including the processing of rRNA (P < 10-10) in
the nucleolus (P < 10-15). Noteworthy, this set of mes-
sages contains 7 of the 15 ribosomal cell-size control
genes (P < 0.01) and regulation of these mRNAs by
Gis2p may relate to the enlarged cell sizes of gis2
mutant cells [16]. Likewise, Gis2p targets can be clus-
tered to protein complexes acting in rRNA processing/
modification, as revealed by analysis for enrichment of
protein complexes with FunSpec, an online tool to
search for common features among a set of yeast genes
[39]. For example, Gis2p targets include the four core
protein components of the H/ACA-box snoRNP (Cbf5,
Gar1, Nhp2, and Nop10), which catalyzes site-specific
pseudouridylation in pre-rRNA, and eight (Nop1, Lcp55,
Mpp10, Sof1, Sik1, Imp4, Nop58, Rrp9) out of nine
proteins (P < 10-6) involved in ribose methylation of
rRNAs, which is carried out by specific snoRNPs that
contain snoRNAs of the C/D-box family [40].
We also found linkage of Gis2p targets with factors
that are involved in regulation of chromosome organiza-
tion or that encode enzymes with hydrolytic activity.
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Figure 1 RNAs specifically associated with yeast Gis2p. (a) Color map of Gis2p-associated transcripts (FDR <5%). Rows represent unique
transcripts ordered according to decreasing FDRs. Columns correspond to individual experiments. Relative enrichment of genes in the individual
RNA affinity isolations is shown in the blue-yellow ratio scale. (b) A selective sample of significantly shared GO terms among Gis2p-associated
transcripts with a FDR <5%. SGD, Saccharomyces Genome Database.
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In particular, Gis2p was associated with 21 of 55 (38%,
P < 2 × 10-5) messages encoding GTPases that regulate
either protein localization or activity, including 11
GTPases that participate in vesicle-mediated transport
(Arl1, Arf1, Arf2, Rhb1, Sec4, Vps21, Ypt1, Ypt6, Ypt31,
Ypt32, and Ypt52). Interestingly, three of the GTPases
are Ras homologs (Ras2, Rho2, and Rsr1), which possi-
bly relate to previous findings that connected Gis2 to
Ras signaling [15].
Since the application of an arbitrarily chosen cutoff to
select genes may not detect weak associations with func-
tional groupings, we additionally analyzed the entire
SAM-score ranked data using the GO enRIchment ana-
Lysis and visuaLizAtion tool (GOrilla), an online tool to
define significantly enriched GO terms in a ranked list
of data (Additional file 4) [41]. Besides the above-men-
tioned GO terms, additional GOs for DNA-related
processes in the nucleus, such as DNA recombination
(P < 3 × 10-5), transcription (P < 9 × 10-5) or chromatin
modification (P < 3 × 10-4) were generally enriched,
possibly reflecting weaker interaction of respective mes-
sages with Gis2p.
Gis2p binds to GAN repeats within coding sequence
of target mRNAs
We next wondered whether there are common struc-
tural features within mRNA targets that could specify
Gis2p interaction. We therefore retrieved the coding
sequences (CDSs) of ORFs from the Saccharomyces
Genome Database (SGD) [42], as well as 3’- and 5’-UTR
sequences [43] for the 50 highest scored Gis2p mRNA
targets, and we searched for common motifs using Mul-
tiple Expectation Maximization for Motif Elicitation
(MEME) as an unbiased motif discovery tool [44] (see
Materials and methods). MEME identified a consensus
sequence composed of 14 GAN trinucleotide repeats
(N refers to any of the four nucleotides) within ORFs
(median approximately 7 GAN repeats) (Figure 2a). No
motif was found among the 3’- and 5’-UTR sequences
[43] or when searching 500 bp downstream or upstream
of these ORFs covering UTRs (data not shown).
Furthermore, GAN repeats are overrepresented in the
ORFs of our experimentally defined Gis2p targets with
FDR <5% (for example, 98 Gis2p targets among all gen-
omically encoded 232 ORFs that bear at least one
(GAN)7 sequence element; P < 10
-22), and ORFs with
greater numbers of GAN repeats tend to be more highly
enriched in Gis2 affinity isolations (the distribution of
(GAN)7-containing ORFs in Gis2-TAP affinity isolations
is shown in Additional file 5). These results let us pro-
pose that Gis2p may bind to stretches of GAN repeats,
which are preferentially located in ORFs/CDSs of
mRNA targets.
To validate some of our experimentally determined
mRNA targets and the in silico predicted RNA recogni-
tion motif, we performed a series of RNA pull-down
experiments with biotinylated RNAs added to extracts
derived from Gis2-TAP cells or with recombinant yeast
Gis2p and human ZNF9 (see Materials and methods).
We tested RNAs derived from four of our experimen-
tally determined Gis2p targets (Fcy1, Erv25, Nop53,
Ras2; Gis2p association with FDRs approximately 0%).
We synthesized RNA fragments covering the ORF,
approximately 500 nucleotides upstream, and approxi-
mately 500 nucleotides downstream of the sequences of
FCY1 and ERV25. Gis2-TAP best interacted with RNA
fragments derived from the ORFs, and substantially
weaker interactions were seen with RNA fragments cov-
ering the 5’-UTR (upstream region), and faint (FCY1) or
no interaction (ERV25) with downstream fragments
including 3’-UTRs. Thus, tagged Gis2p interacts prefer-
entially via RNA elements located in the ORFs of these
messages (Figure 2b). To test for potential involvement
of GAN repeats within the natural context, we further
analyzed the interactions of Gis2p with fragments
derived from ORFs of NOP5 and RAS2. As expected,
Gis2p bound efficiently to a transcript encompassing the
sequence (GAA)7 (Nop53-GAN), but it did not interact
with a similarly sized control fragment that lacks GAN
repeats (Nop53-ctrl) (Figure 2c). Moreover, addition of a
ten-molar excess of Nop53-GAN RNAs to the assay
strongly prevented binding of Gis2p to biotinylated
RNAs, but no competition was seen with the Nop53-ctrl
RNA (Figure 2c). Likewise, two fragments derived from
the RAS2 CDS, both containing a (GAN)3 sequence, effi-
ciently pulled-down tagged Gis2p that was either
derived from yeast (eGis2-TAP) or heterologously
expressed and purified from Escherichia coli (pGis2-His;
Figure 2d). Noteworthy, we repeatedly observed that
Gis2p was approximately two-fold more efficiently
recovered with one of the fragments (Ras2-ORF1), pos-
sibly due to the presence of a (GAN)2NNNGA sequence
located 39 nucleotides upstream of a (GAN)3 sequence.
In conclusion, these results confirm specific interactions
of Gis2p with four of our experimentally defined mRNA
targets, and further indicate that Gis2p preferentially
associates with RNA elements that enclose GAN repeats
in CDSs. To our knowledge, Gis2 is therefore the first
ZnF protein known to bind to CDSs.
Conserved RNA and DNA binding specificities of yeast
Gis2p and human ZNF9
Since yeast Gis2p and human ZNF9 are well conserved
across the seven ZnFs, we wondered whether the respec-
tive RNA binding preferences are conserved as well. To
examine this idea and to gain a more detailed insight into
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the RNA-binding specificities of the yeast and human
protein, we tested a series of short 30-mer RNA oligonu-
cleotides, comprising ten trinucleotide (triplet) repeats in
RNA pull-down assays. We therefore incubated the
RNAs with yeast extracts containing either tagged pro-
tein (eGis2-TAP, eZNF9-TAP) or with partially purified
proteins expressed in E. coli (pGis2-His, pZNF9-His; see
Materials and methods) to evaluate whether the observed
interactions are direct. Biotinylated (GAUGAA)5 effi-
ciently pulled-down Gis2p as well as ZNF9, which is in
agreement with our postulated necessity of GAN repeats
for protein interaction (Figure 3a). Thereby, guanosine at
the first position of the triplet is essential for interaction
as no binding was seen with short RNAs in which half of
the Gs were changed to uridine (GAUUAA)5. We further
analyzed binding selectivity for the second and third
position of the triplet repeats: RNA oligos (GAUGUU)5
and (GUUGUU)5, in which adenosines at the second
and/or third position were changed to uridine, still
bound Gis2p and ZNF9. However, changing the adeno-
sines at the second position to cytosine (GAUGCU)5 or
to guanosine (GUGGUG)5 almost completely abrogated
binding. Likewise, we observed substantially weaker bind-
ing to (GUGGUG)5 and (GACGAC)5, where the third
position of the triplet was changed to guanosine and
cytosine, respectively (Figure 3a, and data not shown). In
conclusion, these experiments demonstrate that both the
yeast and human protein bind specifically to GWW
repeats (W = A/U). Noteworthy, this consensus is some-
what different to the GAN repeats enriched among the
experimentally defined Gis2p targets. A search among all
yeast ORFs for the presence of (GUN)3 trinucleotide
repeat sequences - which includes the potential GUA
and GUU binding sites for Gis2p - revealed that these
sequences are simply not present among yeast ORFs.
Thus, although Gis2p has broader specificity for GWW
repeats, it can only associate with GA(A/U) repeats in
yeast ORFs because of restrictions set by the genome.
To test how many (GWW) repeats are optimal for
Gis2p and ZNF9 binding, we further designed RNA
probes with various numbers of GWW repeats flanked
by (GCU)5 sequences. This design was imposed to form
a defined stem-loop secondary structure displaying the
GWW repeats in the unstructured loop as single
stranded RNA, although some steric hindrances may be
caused by the artificial stem (Figure 3b). We found that
association of both Gis2p and ZNF9 with RNA gradually
increased with the number of GWW repeats: three
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Figure 2 Gis2p preferentially binds to coding sequences that bear GAN repeats. (a) Conserved sequence element in the ORF of Gis2p
targets identified with MEME. The E-value reflects the probability to detect the motif by chance. (b) RNA-protein complexes formed between
biotinylated RNA fragments and Gis2-TAP were purified on streptavidin beads and monitored by immunoblot analysis. Representative
experiments from at least three biological replicates are shown. Biotin labeled fragments comprising the 5’-UTRs (lanes 2 and 5), ORFs (lanes 3
and 6), and 3’-UTRs (lanes 4 and 7) of Erv25 and Fcy1 were incubated with extracts of Gis2-TAP expressing cells (lane 1). Eno2-5’UTR (lane 8) is a
negative control RNA derived from the ‘non-target’ ENO2 (lane 8) and a sample without RNA (lane 9) was used to control for RNA-independent
binding to the beads. (c) RNA pull-downs with RNA fragments derived from NOP53. Nop53-GAN (lanes 3 and 7 to 9) contains a GAN-rich
sequence element whereas the similarly sized fragment Nop53-ctrl does not (lanes 4 and 10). Erv25-ORF (lane 2) and Eno2-ORF (lane 5) are
positive and negative control RNAs, respectively. Binding of Gis2-TAP to Nop53-GAN was competed with a ten-fold excess of non-biotinylated
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GWW repeats were minimally required to detect robust
binding, best binding was seen with six to eight repeats,
and more than eight repeats did not further enhance
binding (Figure 3b). Since these proteins harbor seven
ZnFs, we speculate that in this case every ZnF interacts
with one GWW repeat, but further experiments are
required to define binding sites in the protein.
ZNF9 has been reported to bind G-rich sequences in
ssDNA [24], and we investigated whether Gis2p binds to
ssDNA as well. We therefore performed competition
assays with RNA or ssDNA (Figure 3c). In agreement
with our previous results, the binding of Gis2p to biotiny-
lated (GAUGAA)5 RNA was strongly reduced by the
addition of excess unmodified (GAUGAA)5 competitor,
but it was only weakly to moderately diminished by addi-
tion of (GAUGCU)5 and (GUGGUG)5. Interestingly,
we reproducibly observed opposite outcomes when
competing with ssDNA. The GWW repeat bearing DNA
fragments (GATGAA)5, (GATGTT)5, and (GTTGTT)5
moderately competed for Gis2p binding, but strong com-
petition was seen with the G-rich oligonucleotide
(GTGGTG)5 (Figure 3c). Likewise, direct DNA pull-
down experiments with biotinylated (GTGGTG)5 DNA
revealed strong association with Gis2p (data not shown).
Thus, these results suggest that Gis2p employs different
selectivity for RNA and DNA, the latter depending on
G-rich sequences [24], which may pinpoint specific roles
for these proteins in DNA and RNA regulation.
GWW repeats occur mostly at the first codon position in
CDSs of Gis2p targets
We examined the distribution of GWW repeats of var-
ious lengths in UTRs and ORFs among all annotated
transcripts and among our experimentally defined list of
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Figure 3 Gis2p and ZNF9 bind specifically to GWW repeats in RNA and to G-rich sequences in ssDNA. RNA-protein complexes formed
between biotinylated RNAs and yeast extracts expressing Gis2-TAP or ZNF9-TAP (eGis2/eZNF9) or recombinant Gis2-His or ZNF9-His purified
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(GAUGCU)5 as negative control (lane 7). Binding of ZNF9 to MYH4 RNA was efficiently competed with ten-fold excess of unlabeled (GAUGAA)5
RNA (lane 6). A reaction without RNA is shown in lane 8.
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Gis2p mRNA targets. GWW stretches occur most fre-
quently in ORFs (for example, 1,057 transcripts with
[GWW]4), which are significantly enriched among our
experimentally defined set of Gis2p targets (235 tran-
scripts) (Table 1). The same analysis with (G[C/G][C/
G])4 repeats, a related motif that is not bound by Gis2p,
revealed only six ORFs that bear this sequence, none of
them being a Gis2p target. The GWW repeats are much
rarer in UTRs: only 55 transcripts have a (GWW)4
motif in the 3’-UTR, among them 22 Gis2p targets (P <
10-5). This analysis indicates that although GWW
repeats occur in different regions of transcripts, most of
them are in CDSs representing likely binding sites for
Gis2p. Thereby, the motifs are preferentially positioned
in-frame (first codon position), which has consequences
for the amino acid composition of the encoded proteins:
1,309 (89%) of the 1,438 (GWW)4 motifs encoded in the
CDS genome, as well as 416 (93%) of 446 the motifs
present in Gis2p targets, start at the first codon position.
Moreover, since GA(A/U) codons specify the polar
acidic amino acids glutamate (GAA) and aspartate
(GAU), it is not further surprising that messages for
proteins that contain stretches of these amino acids are
preferentially targeted by Gis2p (for example, 93 of 229
(D/E)7-containing proteins are among our experimen-
tally defined Gis2p targets; P < 3 × 10-14). A similar bias
has recently been seen for Khd1p, which preferentially
binds to CNN repeats that are positioned in-frame in
CDSs [45]. Whether the preference for certain RBPs to
interact with short triplet repeats positioned in-frame in
CDSs has some functional implications has to be further
investigated, but it may indicate some functional link to
translation.
Despite these correlations with GWW repeats, we wish
to note that as we did not detect the cognate consensus
sequence elements in all the experimentally identified tar-
gets, alternative sequences or structural elements in the
RNA might also allow specific interactions with Gis2p; for
instance, the repeats could be dispersed in the transcript
(for example, RAS2). Some mRNAs may also have been
associated indirectly as part of larger complexes.
Conservation of functional groups among yeast and
predicted human mRNA targets
The identification of a defined recognition motif in the
RNA for these ZnF proteins allows the prediction of
human mRNA targets of ZNF9. We retrieved annotations
for all yeast and human protein coding genes that bear
GWW repeats of various lengths within their CDSs (a list
of these yeast and human genes is provided in Additional
files 6 and 7, respectively), and we searched for signifi-
cantly enriched GO terms among them with AMIGO.
We found a remarkable coincidence of functional classifi-
cations of the proteins encoded by the human and yeast
messages, such as ribosome biogenesis, chromatin modi-
fication, and GTPase mediated signaling pathways
Table 1 Number of GWW motifs found in all transcripts and among Gis2p targets
Motif Location Number of motifsa Number of Gis2 targets P-valueb
(GWW)3 ORF 3,550 606 0.7
3’-UTR 347 77 0.01
5’-UTR 191 26 0.24
(GWW)4 ORF 1,057 235 2 × 10
-8
3’-UTR 55 22 4 × 10-5
5’-UTR 20 3 1
(GWW)5 ORF 280 106 1 × 10
-17
3’-UTR 10 1 1
5’-UTR 1 1
(GWW)6 ORF 106 55 9 × 10
-17
3’-UTR 4
5’-UTR 1
(GWW)7 ORF 61 34 5 × 10
-12
3’-UTR 4
(GWW)8 ORF 35 20 8 × 10
-8
3’-UTR 3
aORFs from SGD (5,885 genes), UTR sequences from [43]. bProbability that motifs are enriched in Gis2p targets by chance (Fisher’s test).
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(Figure 4). Most of these themes were also seen among
the experimentally determined Gis2p targets, further
substantiating the predictive power of our analysis
(Figure 1b). Functionally related groups that were exclu-
sively present in either organism mainly relied on the
absence of homologous proteins. Foremost, we were
intrigued by the significant enrichment of transcripts of
genes that code for proteins acting in ‘muscle contrac-
tion’ and ‘muscle system process’ among the predicted
ZNF9 targets. This includes nine genes coding for micro-
filament motors (MYH2, MYH3, MYH4, MYH7, MYH9,
MYH10, MYH13, MYO3A, MYO6; P < 2.5 × 10-6), four
genes encoding proteins of the troponin complex
(TNNT2, TNNT3, TNNI1, TNNI2; P < 5.4 × 10-3) and
five genes for voltage-gated sodium channels (SCN3A,
SCN4A, SCN7A, SCN9A, SCN11A; P < 2 × 10-3), which
are required for action potential production and propaga-
tion in muscle cells and hence are a prerequisite for mus-
cle contraction [46].
We further tested the binding of ZNF9 to predicted
human targets encoding muscle proteins by RNA pull-
down assays (Figure 3d). We examined transcripts
encompassing the CDSs for M-RAS, encoding a muscle-
specific RAS protein; the myosin heavy chain protein
MYH4, which is primarily expressed in skeletal muscles;
and fukutin (FKTN), the locus for Fukuyama congenital
muscular dystrophy. ZNF9 selectively interacted with all
of those RNA substrates, likely via four (MYH4, FKTN)
or five (M-RAS) consecutive GWW repeats located in
CDSs (Figure 3d).
Conserved impact of Gis2 and ZNF9 on cell size and
growth
Puzzled by the finding that functionally related groups
such as rRNA biogenesis components and components
of the Ras signaling pathway were particularly shared
between the yeast Gis2p and predicted human ZNF9
mRNA targets, we wondered whether the human ZNF9
protein could complement the large cell-size phenotype
of gis2Δ mutant cells [16]. We therefore compared the
cell sizes of gis2Δ mutant and wild-type cells with gis2Δ
cells that overexpress GIS2 or ZNF9 on a plasmid
(Figure 5a). Whereas gis2Δ cells showed a significantly
larger size compared to the control (P = 0.0001), we
found that gis2Δ cells overexpressing GIS2 or ZNF9
were of similar sized to wild-type cells, showing that
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Figure 4 Significantly shared GO terms among predicted Gis2p and ZNF9 mRNA targets. GO term enrichments were assessed for
predicted mRNA targets with GWW repeats of different lengths in CDSs. Numbers in brackets indicate the total number of genes in the
respective group for which GO annotations were available. The color intensity corresponds to the log10 P-value. GO terms labeled in green were
only enriched in yeast, the ones in blue only in human. ncRNA, non-coding RNA.
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both orthologs can fully rescue the gis2Δ phenotype.
Likewise, we found that the previously reported slight
vegetative growth defect of GIS2 overexpressing cells
could be fully recapitulated by ZNF9 overexpression
[47] (Figure 5b). Thus, ZNF9 can complement GIS2-
dependent phenotypes in yeast, suggesting functional
conservation between homologous proteins. This is in
accordance with our finding that both proteins recog-
nize identical elements in mRNAs coding for similar
functional classes of proteins.
Gis2p selectively represses expression of ribosome
biogenesis factors and increases expression of motor
proteins
To analyze the global impact of Gis2p on gene expres-
sion, we compared mRNA levels of gis2Δ cells with
wild-type control cells grown to mid-log phase using
DNA microarrays (normalized microarray data are pro-
vided in Additional file 8); 227 genes representing 4% of
all analyzed features changed more than 1.5-fold with
P < 0.05 (one sample t-test), indicating that deletion of
GIS2 does not drastically affect global mRNA expression
(Venn diagrams displaying the fraction of up- or down-
regulated genes are shown in Additional file 9). Among
the 190 up-regulated features are 40 (21%) Gis2p tar-
gets, which are thus slightly overrepresented (P = 0.05,
Chi-square test). A search for common functional attri-
butes among the differentially regulated genes indicate
some overrepresentation of ribosomal proteins among
the up-regulated ones (15 genes, P < 0.008), and 9 out
of 36 down-regulated genes code for proteins that act in
pheromone response (P < 2.2 × 10-8) (a list of signifi-
cantly enriched GO terms is given in Additional file 8).
We also performed the opposing experiment and over-
expressed GIS2. Therefore, yeast cells harboring a plas-
mid with GIS2 under the control of a galactose-inducible
promoter, and control cells containing an empty plasmid,
were grown to mid-log phase, and expression was
induced for 1.5 hours with 2% galactose. We reasoned
that inducible short-time overexpression may be benefi-
cial to minimize secondary effects that may occur after
prolonged changes in Gis2 expression levels, as possibly
seen in gis2Δ cells. The relative changes in mRNA and
protein levels of GIS2-overexpressing compared to con-
trol cells were then measured with DNA microarrays and
quantitative mass spectrometry (qMS), respectively. We
obtained mRNA data for 6,129 genes and quantitative
proteomics data for 1,203 different proteins (raw data
from the microarray and qMS analysis upon GIS2 over-
expression are provided in Additional files 10 and 11,
respectively). Compared to the control, GIS2 expression
was increased 40-fold at the mRNA level and 12-fold at
the protein level, which represents the highest fold-
change in both mRNA and protein levels of all analyzed
features, thus validating our experimental setup. There
was minimal correlation between relative changes of
mRNA and protein levels (Figure 6a; Pearson r < 0.1),
possibly due to the observed mild effects on global
mRNA and protein levels upon GIS2 overexpression.
About 5% of all analyzed mRNAs and proteins changed
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Figure 5 Phenotypic analysis of yeast cells. (a) Cell-size analysis. Wild-type (WT) and gis2Δ cells harboring either the empty vector (+ pBG) or
galactose-inducible GIS2 or ZNF9 were grown in synthetic medium supplemented with 2% galactose to late mid-log phase. The cell area
relating to the cell-size is depicted for 50 cells and the average is marked with a black line (***P < 0.0001). (b) Vegetative growth. WT cells or
gis2Δ cells harboring either the empty vector (+ pBG) or galactose-inducible GIS2, ZNF9 or SLF1 (positive control for vegetative growth defect)
were serially diluted (1:5) and spotted on the indicated plates: SC -Ura, synthetic complete medium lacking uracil; SG -Ura, the same as SC -Ura
but also containing galactose instead of 2% glucose.
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relative expression by at least 1.5-fold with P < 0.05
(Additional file 9). Thereby, Gis2p targets are signifi-
cantly overrepresented among the up-regulated tran-
scripts and proteins (54 out of 205 up-regulated
transcripts (26%, P = 10-5); and 11 out of 28 up-regulated
proteins (40%, P = 0.025)). Some common functional
attributes could also be assigned to the differentially
expressed transcripts/proteins (see Additional files 10
and 11 for GO analysis of up- and down-regulated tran-
scripts). Noteworthy, both myosin II binding proteins
(Mlc1, Mlc2) in yeast were among the 28 up-regulated
proteins (P < 0.0006).
To globally delineate the impact of Gis2p expression on
the fate of mRNA targets and proteins levels, we further
analyzed relative expression changes of Gis2p targets (FDR
<5% in Gis2p affinity isolations) in the mRNA and protein
expression datasets. RNA expression data were available
for 973 (98%) of the 995 defined Gis2p target transcripts,
and qMS data for 265 (27%) of the encoded proteins.
Apparently, there is no ‘simple’ correlation between GIS2
expression and the fate of its targets, as the relative expres-
sion of the 973 Gis2 targets (FDR <5%) was neither com-
monly increased nor decreased in GIS2 overexpressing/
mutant cells compared to all ‘non-target’ mRNAs (P ~
0.3) or proteins (P = 0.34). However, combinatorial bind-
ing of RBPs may greatly impinge on simple linear correla-
tions between expression levels of RBPs and its targets [9].
Since RPBs often bind to functionally related target sets,
we reasoned that such combinatorial control could lead to
the partition of targets for an RBP into functionally related
subsets with different outcomes for their mRNA fates (see
later discussion). To address this, we analyzed expression
changes of Gis2p targets within particular GO clusters
(Figure 6b). Indeed, we found different and significant reg-
ulatory responses between functionally related subsets of
mRNA targets on a global scale.
In a first instance, we found that mRNA levels for 104
Gis2p targets coding for rRNA processing factors
(GO:0006364) were significantly increased in gis2Δ
mutants compared to all genes (Figure 6b); these targets
were also differentially expressed compared to the
remaining 145 non-Gis2p targets annotated to this GO
term (P = 0.0002, Mann-Whitney U test). Likewise, data
were obtained for genes assigned to the nucleolus
(GO:0005730), which is the cellular compartment were
rRNA processing occurs; the 116 Gis2p targets were
slightly up-regulated in gis2Δ mutants, and their expres-
sion differed significantly from 150 nucleolar non-Gis2p
targets (P < 0.001, Mann-Whitney U test). Opposite to
gis2Δ mutants, mRNA and protein levels of Gis2p tar-
gets coding for rRNA processing and nucleolar proteins
were significantly decreased in GIS2 overexpressing cells
(Figure 6b). In these cases however, the expression levels
of non-Gis2p targets assigned to the respective GO
terms were not significantly different from those of
Gis2p targets (P = 0.07), although their average expres-
sion was slightly less diminished (delta log2 ratio =
0.05). Nevertheless, these results indicate that Gis2p
selectively represses the expression of this group of mes-
sages, which could connect to the observed phenotypes
regarding cell-size and growth.
In another instance, we found that the relative mRNA
expression levels for proteins with GTPase activity
(GO:0003924) were significantly lowered in GIS2 overex-
pressing cells, whereas levels of mRNAs coding for pro-
teins involved in the establishment and maintenance of
chromatin architecture (GO:0006325) were significantly
increased upon GIS2 overexpression, exemplifying differ-
ential effects on different functional subsets of targets.
Notably, in both of these cases, Gis2p targets were differ-
entially expressed compared to non-Gis2p target genes
within respective GO groups (GTPase activity, P = 0.03;
chromatin architecture, P < 0.001; Mann-Whitney U
test), further indicating specific effects on Gis2p targets
within functionally related groups of messages. On the
other hand, mRNA expression levels of these groups of
messages were not significantly altered in gis2Δ cells. The
regulatory effect on these messages may therefore reflect
a short-term response upon GIS2 activation, which can-
not be seen in gis2 mutant cells that have been grown for
many generations, allowing adaptation to certain regula-
tory programs induced by the loss-of-function.
In a third instance, we recognized that levels of the
myosin light chain proteins Mlc1, Mlc2, and type I myo-
sin Myo3, which are all assigned to the GO term ‘motor
activity’ (GO:0003774), were significantly increased upon
GIS2 overexpression (mean log2 ratio = 0.9; P = 7 × 10
-4),
but the respective mRNA levels remained unchanged.
Importantly, the protein levels of four non-Gis2p targets
assigned to this GO term were not altered (mean log2
ratio = -0.06) and were differently expressed compared to
Gis2p targets (P = 0.0032, Student’s t-test). This indicates
that Gis2p may specifically regulate translation of this
related group of targets. In conclusion, these results show
that Gis2p differentially affects the expression of func-
tionally related subsets of targets at either the mRNA or
protein level, suggesting strong coordinative functions of
Gis2p for gene expression.
Discussion
Based on our experimentally defined list of Gis2p
mRNA targets and a series of RNA pull-down experi-
ments, we were able to map the RNA-binding selectivity
for Gis2p and human ZNF9. Rather unexpectedly, we
found that both proteins have quasi-identical RNA-bind-
ing specificities, best interacting with RNAs that bear six
to eight GWW repeats (W = A/U; Figure 3). Moreover,
we provide data showing that Gis2p also binds to G-rich
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ssDNA, as previously reported for human ZNF9 [24].
We believe that these interactions are most likely estab-
lished by all or a subset of the seven highly conserved
CCHC-type ZnFs, where each of the ZnFs interacts with
one GWW tri-nucleotide in RNA (Additional file 1).
This scenario appears plausible considering previous
detailed analysis of the RNA- and DNA-binding proper-
ties of ZnF proteins. Analogous to GWW repeats, cer-
tain classes of DNA-binding ZnF proteins contact the
three adjacent nucleotides of GNN triplets [48]. More-
over, the closely related two CCHC knuckles of the
nucleocapsid protein of HIV-1 specifically recognize an
exposed guanosine base located in a single-stranded
G-rich loop of the RNA [49]; and binding of ZnFs to
AU-rich sequences in RNA has been demonstrated for
human Tis11d, which bears two CCCH class ZnF
domains [50]. On the other hand, the ZnF-dependent
interaction with RNA/DNA by Gis2p/ZNF9 is somewhat
in contradiction to a previous report that suggested
strong involvement of the RGG box in ZNF9 for RNA
binding [51]. Since the RGG box is exclusively present
in human and vertebrates but absent in yeast and inver-
tebrates (Drosophila melanogaster (CG3800), Caenor-
habditis elegans (K08D12.3)), we speculate that the
RGG box could direct interactions with other RNA ele-
ments, possibly to G-rich RNA elements located near
TOP sequences in the 5’-UTR of messages encoding
translation factors (note that TOP sequences are not
present in yeast) [25-27]. Noteworthy, RNA binding
through the RGG-box to G-rich elements has been
found to be relatively weak (Kd about 10 μM) [24], and
thus may require stabilization by other proteins in vivo
as previously reported [26]. Further mutational analysis
of protein motifs will be required to resolve the contri-
bution of individual domains to RNA binding.
In accordance with the post-transcriptional operon
model [10,52], we found common functional groups that
were significantly enriched among the Gis2-associated
mRNAs (Figures 1b and 4). Many of the yeast themes
could directly relate to phenotypes, such as rRNA proces-
sing factors and components of the Ras pathway, which
are known regulators of cell size. It appears that many of
these functional groups are shared among predicted
human targets. Such strong functional conservation
among mRNA targets is distinct from previous findings
with other evolutionarily conserved RBPs. In the case of
the Pumilio/FBF (PUF) family proteins in yeast, flies and
human, the PUF RNA-binding domain is well-conserved
as is the sequence motif to which this domain binds;
however, the functional attributes encoded by the bound
messages dramatically diverged [8,53]. Possibly, this dis-
cordance may relate to the location of RBP-binding
motifs: PUF proteins mainly bind to motifs located in
3’-UTRs, and we previously proposed that the acquisition
or loss of RBP-binding motifs in UTRs provides a fluid
evolutionary mechanism to modify post-transcriptional
regulatory connections [8]. Contrarily, CDSs have been
more conserved during evolution [54] and thus may pro-
vide a mechanism to preserve post-transcriptional regula-
tory networks. Nonetheless, the predicted ZNF9 targets
additionally included mRNAs encoding proteins involved
in muscle contraction, such as myosins, troponins, and
ion channels, and for some of them we confirmed bind-
ing by ZNF9 with RNA pull-down assays (Figure 3d).
Since ZNF9 is prominently expressed in heart and mus-
cle in humans [28] these messages could be reached by
ZNF9 for regulatory purposes. Whether and how ZNF9
impacts on these messages is not known, but if so, we
hypothesize that altered ZNF9 activity could lead to
altered ‘coordination’ of gene expression with potential
consequences for muscle function and/or biogenesis.
In support of these speculations are phenotypes seen in
ZNF9+/- heterozygous mice that show some of the char-
acteristic abnormalities of DM, including myotonia, ocu-
lar cataracts, cardiac arrhythmia, and both proximal and
distal muscle wasting [34]. Likewise, the ZNF9 homolog
in C. elegans (K08D12.3) is prominently expressed in
muscle cells and knock-down mutants have defects in
locomotion [55].
Our matched-sample proteome-transcriptome analysis
showed that Gis2p does not linearly affect the expres-
sion of its mRNA targets, but rather adds differential
effects to functionally related subsets (Figure 6). This
adds to previous observations on the impact of RBPs on
the fate of particular RNA targets, which can be contro-
versial, possibly because other RBPs participate in the
regulation of bound messages [3,45,56]. For example,
Khd1p, a well-expressed yeast RBP that targets hundreds
of messages, is required for translational repression of
certain messages during transport to the bud-tip in
dividing yeast cells; but it also positively affects expres-
sion of other messages through mRNA stabilization
[45]. Indeed, comparing Gis2p RNA targets with the
experimentally defined targets for more than 40 differ-
ent yeast RBPs [9] reveals that RNA targets for 12 RBPs
(Cbc2, Gbp2, Msl5, Nab2, Npl3, Nrd1, Nsr1, Pab1, Pin4,
Puf5, Puf5, Vts1) significantly overlap with Gis2p tar-
gets, indicating great potential for combinatorial control
(Additional file 12 depicts the overlap of Gis2p targets
with RNA targets for 36 RBPs). Most prominent, 68% of
the RNA targets of Gbp2 - a shuttling RBP involved in
mRNA export and associated with ribosomes [57,58] -
were among our experimentally defined Gis2p targets
(P < 10-132, hypergeometric distribution). This subset
comprises 259 annotated gene transcripts; a substantial
fraction of them (46 genes, 17.8%) code for proteins
acting in rRNA processing (P < 3 × 10-15). Likewise,
36% of Nsr1p RNA targets were associated with Gis2p
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(384 of 1,049 Nsr1 targets, P < 10-64). Nsr1 is a nucleo-
lar protein required for pre-rRNA processing and ribo-
some biogenesis [59]. A significant fraction of the
messages bound by Nsr1 and Gis2 proteins code for
structural components of the ribosomes (35 genes, P <
2 × 10-7) or have pyrophosphatase activity (40 genes,
P < 5 × 10-5), which includes 13 GTPases (P < 0.0003)
covering most of the Gis2p GTPase target messages
(65%, 13 of 20 GTPases with Nsr1 data). Whether and
how such combinatorial arrangement may impinge on
the fate of particular mRNAs is not known at this point,
but it becomes apparent that strong combinatorial
control on Gis2p targets is very likely and - as we
speculate - may represent a source for differential out-
come of their fates.
On the other hand, differential outcomes of mRNA
fates may also be directed by temporally or spatially
restricted direct interactions of Gis2p with other factors
that participate in RNA regulation. In this regard, data
from large-scale yeast interactome analysis suggests that
Gis2 interacts with at least 28 RBPs that play a role in
translation, RNA decay or rRNA processing (in total, 48
physical or genetic interactions are reported in SGD as
of October 2010). For instance, Gis2p physically inter-
acts with the translation initiation factor 2A (Ygr054p)
and the cytoplasmic ATP-dependent RNA helicases
Dbp1, Dbp2, and Dhh1, as well as with Lsm1 and Lsm6,
which are found in association with the Pat1 decapping
enzyme and Xrn1 exoribonuclease involved in mRNA
degradation. There are also diverse reports on physical
and genetic interactions of Gis2 with rRNA processing
factors (Nop1, Pop1, Pop7, Pwp1, Prp7, Gar1 and
others), which coincidences with our observed prefer-
ence of Gis2p to target related transcripts coding for
proteins acting in this process. Considering this strong
bias for interaction partners acting in RNA-related pro-
cesses, it appears plausible that Gis2p could connect
RNA regulons to different layers of post-transcriptional
gene regulation (for example, translation/decay). The
observed regulatory impact on specific RNAs may be
relatively weak with respect to the amplitude of regula-
tion, but it may still become biologically significant
when considering all messages in a RNA regulon. Such
coordinate function for gene expression may be impor-
tant for fine-tuning the expression of functionally
related groups, complexes, or pathways. It could also
provide a means to reduce arbitrary ‘fluctuations’ or
‘noise’ within gene clusters, tightly balancing transcript
and protein levels. In this regard, the compensative
changes in gene expression may be preferentially noticed
upon short-term changes of RBP expression, as some
regulatory patterns could be more readily seen after
short-term induction of Gis2 expression than after pro-
longed depletion. Lastly, we wish to note that besides
acting as a post-transcriptional ‘coordinator’, we cannot
exclude that Gis2p may also act as a transcriptional reg-
ulator under certain circumstances as we have shown
potential binding to ssDNA. However, to our knowledge
no direct physical interactions of Gis2p with DNA-bind-
ing factors have been reported in the SGD. Since Gis2p
is preferentially localized to the cytoplasm, such func-
tion may involve re-localization to the nucleus, which
could be directed by post-translational modification of
the protein. Further investigations are required to
delineate the molecular details of Gis2p function in gene
expression.
Conclusions
In this study, we provide an integrated analysis defining
potentially conserved RNA regulons for homologous
ZnF proteins in yeast and human. These predictions
were defined by repetitive sequence elements located in
CDSs of messages, which is different to RBPs that bind
to sequence elements located in UTRs. In addition, our
analysis provokes speculation about an alternative role
of human ZNF9 in the regulation of muscle-specific
genes, which may be linked to DM-related phenotypes
seen in ZNF9 mouse models. Finally, we established glo-
bal effects of Gis2 expression on mRNA targets, show-
ing that Gis2p does not linearly affect their expression
but rather differentially effects functional subsets of its
targets, first exemplifying distinct coordinative roles for
RPBs on functional target groups.
This analysis highlights the potential of combining
RNA-binding protein immunopurification-microarray
(RIP-Chip), transcriptome and proteome analysis in
order to generate an integrated view of gene networks
that are coordinated by RBPs. In the future, this approach
may be used to decipher the structure and plasticity of
RNA regulons met by RBPs in a wide range of species,
following reactions of internal and external stimuli that
will reveal conserved and divergent response pathways.
Materials and methods
Yeast strains, plasmids, and media
TAP-tagged Gis2 (YNL255) [18], the isogenic wild-type
strain BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)
and a GIS2 deletion strain (gis2Δ) were obtained
from Open Biosystems (Huntsville, AL, USA). Plasmids
pBG1805-Gis2 and pBG1805-Slf1 for expression of
tagged-proteins under the control of a galactose indu-
cible promoter [60] were from Open Biosystems;
pBG1805-ZNF9 was constructed by Gateway subclon-
ing (Invitrogen, Paisley, UK) of the CDS of ZNF9 from
pDONR-221-ZNF9 into pBG1805. Plasmids for expres-
sion of (His)6-tagged fusion proteins in E. coli were
generated as follows. The CDS of GIS2 was subcloned
from plasmid pBG1805-Gis2 into pDONR-221 by
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Gateway cloning (Invitrogen). The CDS of human
ZNF9 was amplified by PCR from HeLa cDNA with
complementary primers ZNF9-Fw and ZNF9-Rev,
which contain Gateway compatible ends (a list of pri-
mer sequences and PCR products is given in Addi-
tional file 13). PCR products were cloned into
pDONR-221 and sequenced, which revealed the ZNF9
isoform 2 (NP_001120665.1). The CDSs of GIS2 and
ZNF9 were excised from the pDONR-221 and sub-
cloned into the E. coli expression vector pDEST-17
(Invitrogen) by Gateway cloning, generating plasmids
pDEST-17-Gis2 and pDEST-17-ZNF9, respectively.
The media to cultivate yeast cells included rich med-
ium (YPD) and synthetic complete (SC) medium [61].
SC media lacking amino acids or other nutrients (SC
-Ura corresponds to SC lacking uracil) were used to
select transformants. SR and SG media were identical
to SC except that they contained raffinose and galac-
tose, respectively, instead of 2% glucose.
RNA immunoaffinity isolations
Affinity purification of Gis2-TAP together with the asso-
ciated RNAs was carried out essentially as described [7].
One-liter cultures of a strain expressing Gis2-TAP or
the wild-type strain BY4741 (mock control) were grown
to an optical density at 600 nm of 0.6 to 0.9 in YPD at
30°C. Cells were harvested by centrifugation, washed
twice with 25 ml of ice cold buffer A (20 mM Tris-HCl
(pH 8.0), 140 mM KCl, 1.8 mM MgCl2, 0.1% Nonidet
P-40, 0.02 mg/ml heparin), frozen in liquid nitrogen,
and stored at -80°C. The cells were thawed at 4°C and
resuspended in 5 ml of buffer B (buffer A plus 0.5 mM
DTT, 1 mM phenylmethanesulphonylfluoride (PMSF),
1 μg/ml leupeptin, 1 μg/ml pepstatin, 20 U/ml DNase
I (Roche Diagnostics GmbH, Mannheim, Germany)
50 U/ml RNasin (Promega. Madison, WI, USA) 0.2 mg/
ml heparin), and mechanically broken with glass beads
with a Tissue Lyser (Qiagen, Hilden, Germany) for
12 minutes at 300 Hz and 4°C. The lysate was centri-
fuged sequentially for 5 minutes at 2,000 g, 12,000 g,
and 16,000 g at 4°C to remove cell debris. The volume
of the extract was adjusted to 5 ml with buffer B and a
100 μl aliquot was removed for reference RNA isolation.
The remaining 4.9 ml extract was incubated with 500 μl
50% (v/v) IgG-agarose beads (Sigma-Aldrich, St. Louis,
MO, USA) in buffer A for 2 h at 4°C under gentle rota-
tion of tubes. The beads were washed once with 5 ml
buffer B for 15 minutes, and three times with 12 ml buf-
fer C (20 mM Tris-HCl (pH 8.0), 140 mM KCl, 1.8 mM
MgCl2, 0.5 mM DTT, 0.01% NP-40, 15 U/ml SUPERa-
se•In (Applied Biosystems/Ambion, Austin, TX, USA;
catalogue number AM2694), 1 μg/ml pepstatin, 1 μg/ml
leupeptin, 1 mM PMSF) for 15 minutes with gentle agi-
tation. The beads were transferred into 1.2-ml micro-
spin columns (BioRad, Hercules, CA, USA; catalogue
number 732-6204) and pelleted by centrifugation for
2 minutes at 6,000g in a table-top centrifuge. The super-
natant was removed and the beads were resuspended in
1.5× bed volumes (375 μl) of buffer C. TAP-tagged
Gis2 was released from the beads by incubation with
80 U of acTEV protease (Invitrogen, catalogue number
12575023) for 2 h at 16°C. RNA from the extract
(input) and from the affinity isolates was purified with
the RNeasy Mini/Micro Kit (Qiagen). Three indepen-
dent affinity purifications were performed with the
Gis2-TAP strain and five mock control isolations with
the untagged wild-type strain.
Growth of gis2Δ mutants and GIS2 overexpressing cells
Fifty milliliters of gis2Δ cells and the respective wild-
type strain BY4741 were grown in YPD at 30°C to an
OD600 of 0.5 to 0.6. Cells were harvested by centrifuga-
tion and washed twice with 800 μl of bi-distilled water,
and RNA was isolated by hot phenol extraction. For
GIS2 overexpression, 100 ml of BY4741 cells bearing
plasmid pBG1805-Gis2 or the empty plasmid pBG1805
(control) were grown in SR -Ura medium at 30°C to an
OD600 of 0.5 to 0.7 and induced with 2% galactose for
1.5 h before harvesting. Total RNA was isolated from
100 μl (1/8) of cells, and the residual cells were resus-
pended in 200 μl of urea buffer (8 M urea, 0.1 M
ammonium bicarbonate) and lysed with glass beads in a
Tissue Lyser (Qiagen). The lysate was cleared by centri-
fugation at 3,000g for 2 minutes at 4°C. To maximize
the recovery of proteins, the pellets containing glass
beads were washed once with 60 μl of urea buffer. The
combined lysate was centrifuged at 12,000g and 16,000g
for 5 minutes each at 4°C. Protein concentrations were
determined with the Bicinchoninic Acid (BCA) Kit
(Thermo Fisher Scientific, Rockford, IL, USA) with BSA
(Sigma-Aldrich) as a reference standard. The extracts
were frozen in liquid nitrogen and stored at -80°C. Two
biological replicates and two technical replicates were
analyzed with microarrays, and three biological repli-
cates were analyzed by qMS.
DNA microarray analysis
Microarray data are available at the Stanford Microarray
Database (SMD) [62] or at the Gene Expression Omni-
bus with accession number [GEO:GSE24005]. Yeast
oligo arrays that contained probes for all annotated
yeast ORFs, non-coding RNAs, and some intergenic
regions were processed and hybridized with fluores-
cently labeled cDNAs as described previously [63]. For
affinity purifications, 5 μg of total RNA from the extract
(input) and up to 50% (approximately 500 ng) of the
affinity purified RNA were reverse transcribed in the
presence of 5-(3-aminoallyl)-dUTP and natural dNTPs
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with a mixture of N9 and dT20V primers, and cDNAs
were covalently linked to Cy3 and Cy5 NHS-monoesters
(GE Healthcare, Little Chalfont, UK), respectively, and
competitively hybridized on microarrays at 42°C for 14
h in formamide-based hybridization buffer. Likewise,
7.5 μg of total RNA was labeled for gene expression pro-
filing of GIS2 overexpressing cells or gis2Δ mutants com-
pared to control cells. Microarrays were scanned with an
Axon Scanner 4200 (Molecular Devices, Sunnyvale, CA,
USA) and analyzed with GenePix Pro 5.1 (Molecular
Devices). Arrays were deposited and computer normal-
ized at the SMD [62]. To identify transcripts that were
specifically enriched with Gis2p, the log2 median ratios
from three independent Gis2p affinity isolations and five
mock control isolations were retrieved from SMD and
exported into Microsoft Excel after filtering for signal
over background >1.8 in the channel measuring total
RNA derived from the extract. Two-class SAM (version
3.02) [35] was performed using t-test statistics on median
centered arrays [8,53], and features with a FDR <5% were
considered to be significantly associated with Gis2p
(Additional file 2). To analyze mRNA expression profiles
of GIS2 overexpression and gis2Δ mutants, the log2 med-
ian ratios from three biological replicates were filtered
for regression correlation <0.5 and signal over back-
ground >1.5 in both channels. In analogy to the pro-
teome profiling, SGD annotated features (January 2009)
that changed expression at least 1.5-fold (average log2
ratio 0.585) with a P-value <0.05 (one-sample t-test with
Acuity 4.0 (Molecular Devices)) were considered to be
significantly changed.
Label-free quantitative mass spectrometry
We applied a recently established technique that is
based on the label-free quantification of peptide patterns
acquired by high mass accuracy mass spectrometry [64].
This method performs with similar reproducibility and
sensitivity as the Isotope-Coded Affinity Tags (ICAT)
methodology, but does not depend on incorporation of
isotope-labeled amino acids. qMS was essentially per-
formed as described previously [64]: 200 μl of protein
extract (2.5 mg/ml) was reduced with 5 mM Tris [2-car-
boxyethyl] phosphine (Thermo Fisher Scientific/Pierce,
catalogue number 20490) for 30 minutes at 37°C and
alkylated with 10 mM iodoacetamide (Sigma-Aldrich,
catalogue number A3221) for 30 minutes at room tem-
perature. The protein sample was diluted 1:4 with
100 mM ammonium bicarbonate (pH 7.8) and digested
overnight with 20 μg of trypsin (Promega) at 37°C. The
protein digest was acidified with formic acid to pH 2.5,
and the sample was loaded onto a reversed phase C-18
Sep-Pak column (Waters, Milford, MA, USA); material,
100 mg; capacity, 1 mg) equilibrated in washing buffer
(5% acetonitrile, 0.1% formic acid in ddH2O). The flow-
through was re-loaded to minimize loss of peptides. The
column was washed with 2 ml of washing buffer and
the peptides were eluted with 700 μl of 80% acetonitrile
containing 0.1% formic acid in ddH2O. The samples
were dried in a SpeedVac (Thermo Fisher Scientific and
re-solubilized in 100 μl of 0.1% formic acid in ddH2O
for mass spectrometric analysis. The liquid chromato-
graphy tandem mass spectrometry (LC-MS/MS) analysis
was performed on a hybrid linear ion trap Fourier-trans-
form ion cyclotron resonance mass spectrometer
(Thermo Electron, San Jose, CA, USA) that was inter-
faced to a nanoelectrospray ion source (both from
Thermo Electron) coupled online to a Tempo 1D-plus
nanoLC (Applied Biosystems/MDS SCIEX, Foster City,
CA, USA). Peptides were separated on a RPLC column
(75 μm × 15 cm) packed in-house with C18 resin
(Magic C18 AQ 3 μm; Michrom BioResources, Auburn,
CA, USA) using a linear gradient from 98% solvent A
(98% water, 2% acetonitrile, 0.15% formic acid) and 2%
solvent B (98% acetonitrile, 2% water, 0.15% formic
acid) to 30% solvent B over 90 minutes at a flow rate of
0.3 ml per minute. MS/MS spectra were searched using
SORCERER-SEQUEST v3.0.3, running on SageN Sor-
cerer, and using SGD (version of June 6 2008, which
contains 6,760 protein entries). Trypsin was specified for
cleavage, allowing for two missed cleavages and one
non-tryptic terminus. Mass tolerance was set to 25 ppm
for monoisotopic precursor ions, and to 0.5 Da for frag-
ment ions. Stable modification for Cys of +57.0214 Da
was used. The identified peptides were processed and
analyzed through the mass spectrometry Trans-Proteo-
mic Pipeline 3.5 (TPP) [65]. The LC-MS/MS data were
quantified by integrating the peak area of the detected
peptides using the software SuperHirn [66] as previously
described [64].
Expression of His-tagged fusion proteins in E. coli
BL-21 (DE3) cells bearing plasmids pDEST-17-Gis2 or
pDEST-17-ZNF9 were grown to mid-log phase in LB
broth supplemented with 100 μg/ml ampicillin (Sigma)
at 37°C. Expression of the His-tagged fusion proteins
was induced by the addition of 1 mM isopropyl-b-D-
thiogalactopyranosid (IPTG, Sigma) for 4 h at 30°C.
Cells were washed twice with ice-cold 50 mM phosphate
buffer (pH 8.0), resuspended in 10 ml of lysis buffer per
2.5 g of cell pellet (50 mM phosphate-buffer pH 8.0, 50
mM NaCl, 10% glycerol, 25 mM imidazole), and lysed
on ice with a sonicator (Sonoplus from Bandelin elec-
tric, Berlin, Germany; 2 × 10 minutes, 60% power). The
cell lysate was cleared by centrifugation at 15,000g for
30 minutes at 4°C. The extract was loaded onto a nitri-
lotriacetic acid-Ni2+ sepharose column and His-tagged
Scherrer et al. Genome Biology 2011, 12:R3
http://genomebiology.com/2011/12/1/R3
Page 15 of 19
proteins were eluted with lysis buffer supplemented with
200 mM imidazole pH 8 as specified by the manufac-
turer (GE Healthcare).
Expression of tagged ZNF9 in yeast
BY4741 cells transfected with pBG1805-ZNF9 were
grown in SR -Ura medium to an OD600 of 0.5 to 0.7.
ZNF9 expression was induced by the addition of 2%
galactose to the media and cells were further grown for
2 h. Cells were collected and extracts were prepared in
IP buffer (50 mM phosphate buffer pH 8.0, 75 mM
NaCl, 5% glycerol, 2 mM MgCl2, 1 mM EDTA pH 8.0,
0.1% Triton X-100, 1 mM DTT, 1 mg/ml BSA, 0.1 mg/
ml heparin, 0.1 mg/ml E. coli tRNA (Roche), 1 mM
PMSF, 1 μg/ml leupeptin (Sigma), 0.8 μg/ml pepstatin
(Sigma), 40 U/ml RNasin (Promega)) with glass beads as
described above.
Synthesis of biotinylated RNAs and RNA pull-down
experiments
DNA templates for biotin-RNA synthesis were either
prepared by PCR from S. cerevisiae or human DNA
with oligonucleotides bearing a T7 RNA polymerase
promotor sequence at their 5’ ends, or by direct anneal-
ing of complementary oligonucleotide pairs containing a
5’ T7 RNA polymerase promotor (a list of oligonucleo-
tide primers is given in Additional file 13). For the
annealing of oligos, a mixture of 1 μM of forward and
reverse complementary oligonucleotides was incubated
for 1 minute at 95°C in 20 μl of water and cooled down
slowly to room temperature. Biotin-labeled RNAs were
prepared with the Biotin RNA Labeling Mix (Roche)
and T7 RNA polymerase (Promega). Biotinylated RNAs
were treated with RNase-free DNase I and purified with
the PureLink Micro-to-Midi Kit (Invitrogen). RNAs
smaller than 60 nucleotides were purified with the mir-
Vana PARIS Kit (Ambion, catalogue number AM1556).
RNA was quantified by UV spectrometry with a Nano-
drop device (Witec AG, Littau, Switzerland), and the
integrity of the RNA was controlled by agarose gel
electrophoresis.
RNA pull-downs were performed in IP buffer essen-
tially as described [8]. Biotinylated RNAs (9 pmol) were
combined with 50 μl of yeast extract (OD280 approxi-
mately 10) prepared from cells expressing either Gis2-
TAP or tagged ZNF9, or with purified His-tagged pro-
teins expressed in E. coli (50 ng/μl). The integrity of
transcripts derived from PCR templates was controlled
with RT-PCR after incubation with extracts; there was
no indication of substantial degradation (data not
shown). Streptavidin-captured RNA-protein complexes
were resolved by SDS-PAGE and subjected to immuno-
blot analysis using PAP reagent (1:5,000; Sigma) to
detect protein A-tagged proteins. His-tagged proteins
were detected with anti-His antibodies (1:1,000; Qiagen)
and horseradish peroxidase-coupled secondary antibo-
dies (1:5,000). Blots were developed with the ECL Plus
Western Blotting Detection System (GE Healthcare/
Amersham) and bands were visualized on a film. Repre-
sentative experiments from multiple replicates are
shown in Figures 2 and 3.
Phenotype studies
Gis2Δ cells or BY4741 wild-type cells were transformed
with either pBG1805 (empty vector control), pBG1805-
Gis2, pBG1805-ZNF9, or pBG1805-Slf1 and grown in
SR -Ura medium at 30°C to an OD600 of 0.5 under con-
stant agitation. For plate assays, cultures were serially
diluted (1:5) and spotted onto SC or SG plates. To mea-
sure cell size, cells transformed with the respective plas-
mids were grown in SG -Ura medium at 30°C to an
OD600 of 1.2 and examined on a microscope slide with
an Axioskop 2 Mot Plus microscope (Carl Zeiss AG).
Images were captured at 40× magnification with an
AxioCam MRm digital camera and analyzed with Axio
Vision 4.4 software (Zeiss). Adobe Photoshop CS4
(Adobe Systems, San Jose, CA, USA) was used for quan-
tification of cell size using the quick selection tool (mea-
surement scale: 1 pixel = 0.155 μm). A two-tailed
Student’s t-test implemented in GraphPad Prism version
5.0 for Windows was used for statistics (GraphPad Soft-
ware, San Diego, CA, USA).
Bioinformatic tools
Yeast ORF CDSs were downloaded from SGD, and
UTR sequences for 5,880 yeast transcripts were taken
from [43]. To search for motifs within nucleotide
sequences, the sense strand was searched with MEME
under the default settings [67]. The number and
location of consensus sequences among yeast ORF
CDSs was obtained by searching with PatMatch in
SGD [42]. The occurrence of GWW motifs within
yeast UTRs was analyzed with an Excel implemented
Pearl Script. Human CDSs were downloaded with Bio-
Mart (ENSEMBL v48). RNA structures were predicted
with Mfold [68,69]. Significantly shared GO terms
among sets of genes were identified with the GO term
enrichment tool at the AMIGO GO database (Decem-
ber 2008/October 2010 versions) [38,70] considering
all SGD and UniprotKB (The Universal Protein
Resource Consortium, UniProt) annotated gene sets as
background database filters for yeast and human genes,
respectively. For the discovery of up- and down-regu-
lated GO gene sets, we used GOrilla [41,71]. FunSpec
analysis of Gis2p targets (FDR <5%) was performed via
the web-based program [39,72]
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Additional material
Additional file 1: Domain structure and amino acid sequence
alignment of Gis2p homologs. (a) Domain structure. CCHC-type ZnFs
are shown in blue, the RGG-box in yellow. (b) Multiple amino acid
sequence alignment of ZNF9 homologs in vertebrates and yeast Gis2p.
The seven CCHC zinc-knuckle motifs are boxed in black, the RGG-motif is
boxed in black with a transparent white background. A color code
representing the physiochemical properties of amino acids is shown
above the alignment. Entrez Protein Database accession numbers:
[AAI02299] (Bos taurus), [AAD33937] (Bufo arenarum), [AAO73520] (Danio
rerio), [AAB62243] (Gallus gallus), [AAA61975] (Homo sapiens), [AAB60490]
(Mus musculus), [BAA08212] (Rattus norvegicus), [CAA69031] (Xenopus
laevis), [AAI22021] (Xenopus tropicalis), and [AAS56328] (Saccharomyces
cerevisiae).
Additional file 2: List of Gis2p RNA targets. Columns indicate the
following (from left to right): ORF; gene name; GO annotations; SAM-
score; FDR; (GWW)4 repeat in the CDS; average log2 ratio and P-value of
relative changes of mRNA levels upon GIS2 overexpression; average log2
ratio and P-value of relative changes of protein levels upon GIS2
overexpression.
Additional file 3: Raw data and SAM analysis of Gis2p affinity
isolates. (a) Log2 ratios of enrichment in three independent Gis2-TAP
affinity isolations and five mock control isolations. (b) SAM analysis with
q-value representing FDRs.
Additional file 4: Significantly shared GO terms among Gis2p mRNA
targets. GO enrichment analysis on the 995 messages associated with
Gis2p with FDR <5% with AMIGO, or with GOrilla on SAM-ranked data. If
multiple related GO terms were retrieved for the same set of genes, only
the most significant terms are shown. GOrilla enrichment = (b/n)/(B/N);
N, total number of genes in the reference database; B, number of genes
in the reference database associated with a specific GO term; n, number
of genes in the target dataset; b, number of genes in the target set
associated with a specific GO term.
Additional file 5: Distribution of ORFs with (GAN)7 repeats in Gis2p
affinity isolates. The number of (GAN)7 motifs is plotted on the y-axis
and ORFs are ranked on the x-axis based on decreasing SAM scores for
Gis2p association. Range of genes with FDR <5% are marked with a bar.
The numbers of (GAN)7 repeats as well as the number of genes with at
least one (GAN)7 repeat in the ORF are indicated for Gis2p targets (red)
and non-targets (green).
Additional file 6: S. cerevisiae CDSs with GWW repeats of various
lengths.
Additional file 7: Human CDSs with GWW repeats of various
lengths representing predicted ZNF9 targets.
Additional file 8: Microarray data representing relative changes
(log2 ratio) of RNA levels of gis2Δ versus wild-type cells (BY4741).
Experimentally defined Gis2p targets are marked in a separate column. A
list of significantly up-regulated and down-regulated genes (1.5-fold, P <
0.05) and a GO enrichment analysis for these genes are given in separate
worksheets.
Additional file 9: Venn diagram representing mRNAs/proteins that
changed upon GIS2 overexpression and in gis2Δ mutants. The
number of all analyzed mRNAs/proteins is indicated in purple, and the
number of experimentally defined Gis2p targets (FDR <5%) is shown in
blue. The number of features for which relative expression was
selectively increased is indicated within the red circle, features with
decreased expression are within green circles (cutoff: mRNAs/proteins
that changed at least 1.5-fold, P < 0.05). P-values relate to the
significance of the overlap (Chi square test).
Additional file 10: Microarray data representing relative changes
(log2 ratio) of RNA levels in GIS2 overexpressing versus control
cells. Data for two biological replicates (1 and 2) and two technical
replicates (a and b) are shown in different columns. Experimentally
defined Gis2p RNA targets are indicated in a separate column. A list of
significantly up-regulated and down-regulated genes (1.5-fold, P < 0.05)
and a GO enrichment analysis are given in separate worksheets.
Additional file 11: Raw qMS data comparing protein levels from
cells overexpressing GIS2 with control cells. Experimentally defined
Gis2p targets are indicated in a separate column. A list of significantly
up-regulated and down-regulated genes (1.5-fold, P < 0.05) and a GO
enrichment analysis are given in separate worksheets.
Additional file 12: Overlap between RNA targets for Gis2p and 36
yeast RBPs. Data for RNA targets for yeast RBPs with FDR <5% were
retrieved from Hogan et al. [9]. Thirty-six RBPs, which had at least eight
RNA targets, were further considered for this analysis. The number of
targets shared with Gis2p and the number of all targets are indicated
next to the name of the RBP. The histogram depicts the fraction of Gis2p
targets among RBP targets. Significant overlaps are marked with asterisks
(hypergeometric distribution with Bonferroni correction; ***P < 10-10, **P
< 10-5, *P < 0.01).
Additional file 13: Oligonucleotide primer sequences.
Abbreviations
BSA: bovine serum albumin; CDS: coding sequence; DM: myotonic
dystrophy; DTT: dithiothreitol; FDR: false discovery rate; GO: Gene Ontology;
Gorilla: Gene Ontology enrichment analysis and visualization; LC-MS/MS:
liquid chromatography tandem mass spectrometry; MEME: Multiple
Expectation Maximization for Motif Elicitation; ORF: open reading frame;
PMSF: phenylmethanesulphonylfluoride; qMS: quantitative mass
spectrometry; RBP: RNA-binding protein; SAM: Significance Analysis of
Microarrays; SGD: Saccharomyces Genome Database; SMD: Stanford
Microarray Database; snoRNA: small nucleolar RNA; SC: synthetic complete;
ssDNA: single-stranded DNA; TAP: tandem-affinity purification; TOP: terminal
oligopyrimidine; UTR: untranslated region; ZnF: zinc finger.
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